OptimizeRx (OPRX) Gross Profit (2013 - 2026)

OptimizeRx has disclosed Gross Profit across 14 years of filings, most recently posting $15.7 million for Q2 2026.

• In Q2 2026, Gross Profit fell 15.81% year-over-year to $15.7 million; the TTM figure through Jun 2026 stood at $72.2 million (up 7.1% YoY), while the FY2025 annual figure was $73.6 million, up 23.94% from the prior year.
• Gross Profit came in at $15.7 million for Q2 2026 at OptimizeRx, up from $14.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $24.1 million in Q4 2025 to a low of $7.4 million in Q1 2023.
• Average Gross Profit over 5 years is $13.6 million, with a median of $12.9 million recorded in 2022.
• Year-over-year, Gross Profit jumped 64.19% in 2024 and decreased 15.81% in 2026.
• Over 5 years, Gross Profit stood at $12.5 million in 2022, then surged by 43.25% to $17.8 million in 2023, then rose by 23.44% to $22.0 million in 2024, then increased by 9.43% to $24.1 million in 2025, then plunged by 34.9% to $15.7 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $15.7 million in Q2 2026, $14.9 million in Q1 2026, and $24.1 million in Q4 2025.